已收录 268921 条政策
 政策提纲
  • 暂无提纲
Bisphosphonates and atypical subtrochanteric fractures of the femur
[摘要] ObjectivesBisphosphonates are widely used as first-line treatment for primary and secondary prevention of fragility fractures. Whilst they have proved effective in this role, there is growing concern over their long-term use, with much evidence linking bi
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 骨科学
[关键词] Bisphosphonates;Atypical fractures of the femur;Femoral geometry;Bone remodelling [时效性] 
   浏览次数:18      统一登录查看全文      激活码登录查看全文